Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cell therapy offers hope for tough blood cancers

NCT ID NCT07070219

Recruiting now Disease control Sponsor: BIOHENG THERAPEUTICS US LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new treatment called CTD402 for people with T-cell acute lymphoblastic leukemia (T-ALL) or lymphoblastic lymphoma (T-LBL) that has come back or not responded to other treatments. Participants receive one infusion of CTD402 and are monitored for safety and how well it fights the cancer. The study includes people aged 12 and older and follows them for up to 2 years, with a separate long-term follow-up for up to 15 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lymphoblastic leukemia lymphoblastic lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence refractory precursor T-lymphoblastic lymphoma/leukemia T-cell acute lymphoblastic leukemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LYMPHOCYTIC LEUKEMIA REFRACTORY LYMPHOMA, LYMPHOBLASTIC

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Colorado Blood Cancer Institute

    NOT_YET_RECRUITING

    Denver, Colorado, 80218, United States

    Contact

  • MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

  • Mayo Clinic - Rochester

    NOT_YET_RECRUITING

    Rochester, Minnesota, 55905, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 11101, United States

    Contact

  • Montefiore Einstein Comprehensive Cancer Center

    RECRUITING

    The Bronx, New York, 10467, United States

    Contact

  • Sarah Cannon Research Insitute

    RECRUITING

    Nashville, Tennessee, 37203, United States

    Contact Phone: •••-•••-••••

  • Stanford University

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Email: •••••@•••••

  • University of Chicago

    NOT_YET_RECRUITING

    Chicago, Illinois, 60637, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.